IRIDEX (IRIX) vs Valion Bio (VBIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
IRIDEX is the larger company by market cap ($15.8 million vs $2.0 million), about 8.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | IRIX | VBIO |
|---|---|---|
| Share price | $0.898 | $2.21 |
| Market cap | $15.77M | $1.96M |
| 1-day change | +2.24% | +0.91% |
| YTD return | -22.96% | — |
| 1-year return | -20.87% | — |
| 5-year return | -88.15% | — |
| EPS (TTM) | $-0.20 | $-177.91 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.65 | $78.75 |
| 52-week low | $0.61 | $2.05 |
| Distance from 52-week high | -45.58% | -97.19% |
| Average volume | 375.83K | 1.46M |
| Shares outstanding | 17.56M | 887.59K |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IRIDEX is about 8.0 times larger than Valion Bio by market value ($15.77M vs $1.96M).
IRIX vs VBIO FAQ
Which is bigger, IRIDEX or Valion Bio?
IRIDEX (IRIX) is larger, with a market capitalization of $15.77M compared with $1.96M for Valion Bio (VBIO).
Are IRIDEX and Valion Bio in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.